Company / Return on Equity (ROE)
AETHLON MEDICAL INC Return on Equity (ROE) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-232.2%
FY2024
5-year range
-232.2% / -65.8%
FY2020-FY2024
Trend
-186.5%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AETHLON MEDICAL INC reports negative total equity of -232.2% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-232.2% in FY2024 with a 3-year CAGR of -164.6%.
Declined from -70.8% to -232.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -164.6pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- AETHLON MEDICAL INC's return on equity (roe) has declined for 4 consecutive years.
- In FY2024, return on equity (roe) decreased 186.5% year-over-year.
- Peak return on equity (roe) was recorded in FY2020.
- Lowest return on equity (roe) in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | -232.2% | -186.5% |
| FY2023 | -81.0% | -14.5% |
| FY2022 | -70.8% | -4.7% |
| FY2021 | -67.6% | -2.7% |
| FY2020 | -65.8% | +34.8% |
| FY2018 | -101.0% | +86.0% |
| FY2017 | -720.4% | -53.7% |
| FY2016 | -468.6% | +78.4% |
| FY2015 | -2170.3% | - |
| FY2014 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026